Vaccine News and Research

Latest Vaccine News and Research

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

The Serum Institute of India plans to start manufacturing Oxford University's COVID-19 vaccine in 3 weeks to get a head start on production, the company announced. This comes even as experts warn that any successful vaccine will take two or more years to come on the market.

28 Apr 2020

COVID-19 can trigger serious inflammatory-related cardiovascular problems

The coronavirus disease (COVID-19) is potentially fatal for vulnerable populations like seniors who over 60 years old, and those with underlying medical conditions, like heart disease, diabetes, and lung disease. Reports show that patients are suffering from heart impairment caused by COVID-19. A new study sheds light on the effect of the novel coronavirus on the heart, causing cardiovascular problems, even in those without underlying heart conditions.

27 Apr 2020

Using neutralising antibodies in the fight against COVID-19

While many scientists and pharmaceutical companies are racing to develop a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, there is also an urgent need for a coronavirus disease (COVID-19) treatment. The potent virus has now spread to 210 countries and territories, affecting more than 3.04 million people. Now, a team of German scientists is working on using antibodies to prevent and treat COVID-19.

27 Apr 2020

Researchers develop new ICU ventilator prototype to fight against COVID-19

Researchers and technicians from the Universidad Carlos III de Madrid and the University Hospital Gregorio Marañón have designed and developed a new ventilator prototype for Intensive Care Units in the fight against the health crisis caused by COVID-19.

27 Apr 2020

SARS-CoV-2 spike protein discovery could pave way for COVID-19 vaccine

Researchers at the Indian Institute of Technology, Guwahati, have made an important discovery about a viral fusion protein found on the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could help researchers develop a vaccine.

27 Apr 2020

Study can lead the way to new treatment methods for hepatitis C in infants

Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease.

27 Apr 2020

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

A new study reports the induction of high levels of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing the current pandemic of COVID-19. This promising finding was reported on the preprint server bioRxiv on April 2020.

26 Apr 2020

Is the BCG vaccine really protective against COVID-19?

A new paper published on the preprint server medRxiv in April 2020 challenges the hypothesis that BCG vaccination confers some degree of protection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the pneumonic illness COVID-19.

26 Apr 2020

Microclimate and turbulent wind can influence COVID-19 spread over long distances

Respiratory particles exhaled after a sneeze can be transported by the turbulent wind more than three times further than current social or physical distancing measures recommend, reports a new study from Chile available on the preprint server medRxiv.

26 Apr 2020

A new test for rapid large-scale testing of COVID-19

OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider

25 Apr 2020

UCLA scientists receive awards to pursue treatments and vaccines for COVID-19

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards to pursue treatments and vaccines for COVID-19 from the California Institute for Regenerative Medicine, the state's stem cell agency.

25 Apr 2020

Resurgence of measles or polio outbreaks likely to happen, experts warn

Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn.

24 Apr 2020

USask's VIDO-Intervac receives $23 million to fast-track development of COVID-19 vaccine

The University of Saskatchewan's VIDO-InterVac (Vaccine and Infectious Disease Organization-International Vaccine Centre) has been awarded $23 million to fast-track efforts to develop a COVID-19 vaccine, Prime Minister Justin Trudeau announced today.

24 Apr 2020

FAU scientists aim to develop a passive vaccine against COVID-19

Nothing less than the development of a passive vaccine against Covid-19 has been undertaken by a team of scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinkum Erlangen and their partners from the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig and the German Primate Centre in Göttingen.

24 Apr 2020

Vaccine News and Research

Latest Vaccine News and Research

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

COVID-19 can trigger serious inflammatory-related cardiovascular problems

Using neutralising antibodies in the fight against COVID-19

Researchers develop new ICU ventilator prototype to fight against COVID-19

SARS-CoV-2 spike protein discovery could pave way for COVID-19 vaccine

Study can lead the way to new treatment methods for hepatitis C in infants

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

Is the BCG vaccine really protective against COVID-19?

Microclimate and turbulent wind can influence COVID-19 spread over long distances

A new test for rapid large-scale testing of COVID-19

UCLA scientists receive awards to pursue treatments and vaccines for COVID-19

Resurgence of measles or polio outbreaks likely to happen, experts warn

USask's VIDO-Intervac receives $23 million to fast-track development of COVID-19 vaccine

FAU scientists aim to develop a passive vaccine against COVID-19

Anti-vaccine activists latch onto coronavirus to bolster their movement

American Lung Association calls for urgent universal COVID-19 antibody testing

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Unprecedented effects of COVID-19 on digital health sector and future considerations

Study highlights a new way to increase crop production

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in